pancreatic neuroendocrine neoplasm
pancreatic neuroendocrine neoplasm
Explore linked clinical trials. Standard reference: MONDO:00058152 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine neoplasm | Recruiting | Not stated | 2026-01-26 | NCT05746182 | |
| Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms | Adenoma, Islet Cell, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, pancreatic neuroendocrine neoplasm | Not yet recruiting | Phase 2 | 2022-04-07 | NCT05316480 |